Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Department of Clinical Haematology

1 abstract

Abstract
Impact of renal impairment (RI) on pharmacokinetics (PK) and clinical outcomes with mezigdomide plus dexamethasone (DEX) in relapsed/refractory multiple myeloma (RRMM).
Org: NIHR UCLH Clinical Research Facility, Department of Clinical Haematology,